Cetera Investment Advisers
GPCR icon

Cetera Investment Advisers’s Structure Therapeutics GPCR Stock Holding History

Cetera Investment Advisers’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$372K Buy
7,720
+1,124
+17% +$76.9K ﹤0.01% 3790
2025
Q4 		$459K Buy
+6,596
New +$269K ﹤0.01% 3508

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Cetera Investment Advisers's GPCR Position: Q1 2026 in Review

Cetera Investment Advisers increased its Structure Therapeutics (GPCR) stake by 17% in Q1 2026, buying an estimated $76.9K and bringing the position to 7,720 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #3790.

Cetera Investment Advisers first reported a position in GPCR in Q4 2025 and has held it in 2 quarters since. The position peaked at $459K in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Cetera Investment Advisers held 7,720 shares of Structure Therapeutics worth $372K as of Q1 2026.
  • Cetera Investment Advisers bought 1,124 Structure Therapeutics shares in Q1 2026, an estimated $76.9K.
  • Structure Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3790 holding.
  • Cetera Investment Advisers first reported a position in Structure Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Cetera Investment Advisers's Structure Therapeutics position peaked at $459K in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.